EMEA-001613-PIP01-14-M03

Key facts

Active substance
tezepelumab
Therapeutic area
Pneumology-allergology
Decision number
P/0263/2019
PIP number
EMEA-001613-PIP01-14-M03
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Subcutaneous use
Contact for public enquiries
AstraZeneca AB (Sweden)

Tel.  +46 855326000
E-mail: paediatrics@astrazeneca.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating